{
  "created_at": "Thu Apr 22 5:51:51 +0000 2021",
  "id_str": "1385095812523433986",
  "full_text": "A mutation of SARS-CoV-2 may be responsible for the sharp rise in covid-19 cases in India. In February we asked whether vaccines will be effective against new variants https://t.co/L0896fjisw",
  "display_text_range": [
    0,
    191
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/L0896fjisw",
        "expanded_url": "https://econ.st/3ek2LIP",
        "display_url": "econ.st/3ek2LIP",
        "indices": [
          168,
          191
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 31,
  "favorite_count": 93,
  "possibly_sensitive": false,
  "original_created_at": "Thu Apr 22 04:59:10 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "SARS-CoV-2の突然変異が、インドでのcovid-19感染者の急増の原因となっている可能性がある。2月の記事では、新しい変異体に対してワクチンが有効かどうかを問いかけました。https://t.co/L0896fjisw"
    },
    {
      "locale": "zh",
      "full_text": "SARS-CoV-2的一个变异可能是造成印度covid-19病例急剧上升的原因。在2月份，我们问到疫苗是否会对新的变种有效 https://t.co/L0896fjisw"
    },
    {
      "locale": "zh-Hant",
      "full_text": "SARS-CoV-2的一個變異可能是造成印度covid-19病例急劇上升的原因。在2月份，我們問到疫苗是否會對新的變種有效 https://t.co/L0896fjisw"
    }
  ]
}